Skip to content
  • About
    • Company Overview
    • Milestones
    • Board of Directors
    • Management Team
    • Organization Chart
    • CSR
  • Pipeline
    • Globo H
      • Adagloxad simolenin (Vaccine)
      • OBI-833 (Vaccine)
      • OBI-888 (mAb)
      • OBI-999 (ADC)
    • SSEA-4
      • OBI-866 (Vaccine)
    • AKR1C3
      • OBI-3424 (Prodrug)
    • Others
      • OBI-858 (Botulinum toxin)
  • News
    • News
    • Company Presentation
  • Investors
    • Investor Overview
    • About
      • Company Profile
      • Corporate Governance
      • Stakeholder
    • News&Events
      • Announcements
      • Event Calendar
    • Financial Information
      • Annual Report
      • Financial Report​
      • Monthly Revenues
      • Stock Quote
  • Careers
  • Contact
  • 繁體中文
  • About
    • Company Overview
    • Milestones
    • Board of Directors
    • Management Team
    • Organization Chart
    • CSR
  • Pipeline
    • Globo H
      • Adagloxad simolenin (Vaccine)
      • OBI-833 (Vaccine)
      • OBI-888 (mAb)
      • OBI-999 (ADC)
    • SSEA-4
      • OBI-866 (Vaccine)
    • AKR1C3
      • OBI-3424 (Prodrug)
    • Others
      • OBI-858 (Botulinum toxin)
  • News
    • News
    • Company Presentation
  • Investors
    • Investor Overview
    • About
      • Company Profile
      • Corporate Governance
      • Stakeholder
    • News&Events
      • Announcements
      • Event Calendar
    • Financial Information
      • Annual Report
      • Financial Report​
      • Monthly Revenues
      • Stock Quote
  • Careers
  • Contact
  • 繁體中文

Financial Report

2020

2020Q1 Consolidated

2020

2020Q2 Consolidated

2020

2020Q3 Consolidated

2020

2020 Consolidated TBD

2019

2019Q1 Consolidated

2019

2019Q2 Consolidated

2019

2019Q3 Consolidated

2019

2019 Consolidated

2019

2019 Parent Company

2018

2018Q1 Consolidated

2018

2018Q2 Consolidated

2018

2018Q3 Consolidated

2018

2018 Consolidated

2017

2017Q1 Consolidated

2017

2017Q2 Consolidated

2017

2017Q3 Consolidated

2017

2017 Consolidated

2016

2016Q1 Consolidated

2016

2016Q2 Consolidated

2016

2016Q3 Consolidated

2016

2016 Consolidated

2015

2015 Consolidated

2014

2014 Consolidated

2013

2013 Consolidated

2012

2012Consolidated

2020

2020Q1 Consolidated
2020Q2 Consolidated
2020Q3 Consolidated

2019

2019Q1 Consolidated
2019Q2 Consolidated
2019Q3 Consolidated
2019 Consolidated
2019 Parent Company

2018

2018Q1 Consolidated
2018Q2 Consolidated
2018Q3 Consolidated
2018 Consolidated

2017

2017Q1 Consolidated
2017Q2 Consolidated
2017Q3 Consolidated
2017 Consolidated

2016

2016Q1 Consolidated
2016Q2 Consolidated
2016Q3 Consolidated
2016 Consolidated

2015

2015 Consolidated

2014

2014 Consolidated

2013

2013 Consolidated

2012

2012Consolidated

Company Overview

Management Team

CSR

Pipeline

News

Investors Overview

Careers

Contact

© 2020 OBI Pharma.Web Development by 展躍設計

We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies.
Cookie SettingsAccept
Manage consent
Required
Always Enabled

Required Cookies is very important on website, including security and functionality. The Cookies doesn't collect your personal information.

Not required

All Cookies required are used. Not required Cookies for collecting personal info, data and advertising.

  •  

  •